Amaravati Life Sciences Private Limited
Founded in 2017 and headquartered in Andhra Pradesh, India.
2017 | Nellore, Andhra Pradesh (India) | Active
Amaravati Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 7.42%
- Profit Growth 82.82%
- Ebitda -22.82%
- Net Worth -52.37%
- Total Assets -9.23%
About Amaravati Life Sciences
Amaravati Life Sciences Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 May 2017 (Seven years and eight months 29 days old ). Its registered office is in Nellore, Andhra Pradesh, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sri Aluri and Shanmukheshwara Uppu serve as directors at the Company.
Company Details
- Location
Nellore, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U72900AP2017PTC105974
- Company No.
105974
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Information Technology
Who are the key members and board of directors at Amaravati Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sri Aluri  | Director | 04-Jul-2022 | Current |
| Shanmukheshwara Uppu | Director | 31-May-2017 | Current |
Financial Performance of Amaravati Life Sciences.
Amaravati Life Sciences Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 7.42% increase. The company also saw a substantial improvement in profitability, with a 82.82% increase in profit. The company's net worth observed a substantial decline by a decrease of 52.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amaravati Life Sciences?
Unlock access to Amaravati Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amaravati Life Sciences?
Unlock and access historical data on people associated with Amaravati Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amaravati Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amaravati Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
